Ultomiris demonstrated statistically significant and clinically meaningful reduction of proteinuria in adults with IgAN in I CAN phase III trial: Cambridge, UK Wednesday, April 22 ...

Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...

That starts with a focus on skills, rather than paper credentials. Read more at straitstimes.com. Read more at ...

As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential best-in-class efficacy and convenience in gMG ...

A new set of drugs exploit a recently-revealed weakness in 'zombie-like' – or senescent – cells that could lead to new ...

Yale researchers have previously shown that people who undergo moderate calorie restriction—a 14% reduction in calorie intake ...

Indian health delivery systems have been facing structural challenges for several decades. These challenges include chronic ...

Digital transformation and artificial intelligence (AI) in health care requires a range of safeguards and standards to work ...

What is World Immunization Week, and why are vaccines important? Learn how vaccination protects every generation.

Therapeutic fasting offers a metabolic approach to chronic pain by shifting to fat metabolism, reducing systemic inflammation ...

Magnesium is an important nutrient involved in many processes in the body. It has been shown to support sleep in several ways ...